The donor risk index: A decade of experience

Liver Transpl. 2017 Sep;23(9):1216-1225. doi: 10.1002/lt.24799.

Abstract

In 2006, derivation of the donor risk index (DRI) highlighted the importance of donor factors for successful liver transplantation. Over the last decade, the DRI has served as a useful metric of donor quality and has enhanced our understanding of donor factors and their impact upon recipients with hepatitis C virus, those with low Model for End-Stage Liver Disease (MELD) score, and individuals undergoing retransplantation. DRI has provided the transplant community with a common language for describing donor organ characteristics and has served as the foundation for several tools for organ risk assessment. It is a useful tool in assessing the interactions of donor factors with recipient factors and their impact on posttransplant outcomes. However, limitations of statistical modeling, choice of donor factors, exclusion of unaccounted donor and geographic factors, and the changing face of the liver transplant recipient have tempered its widespread use. In addition, the DRI was derived from data before the MELD era but is currently being applied to expand the donor pool while concurrently meeting the demands of a dynamic allocation system. A decade after its introduction, DRI remains relevant but may benefit from being updated to provide guidance in the use of extended criteria donors by accounting for the impact of geography and unmeasured donor characteristics. DRI could be better adapted for recipients with nonalcoholic fatty liver disease by examining and including recipient factors unique to this population. Liver Transplantation 23 1216-1225 2017 AASLD.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Donor Selection / methods*
  • Donor Selection / trends
  • End Stage Liver Disease / mortality
  • End Stage Liver Disease / surgery*
  • End Stage Liver Disease / virology
  • Graft Survival
  • Hepacivirus / isolation & purification
  • Humans
  • Liver / pathology
  • Liver Transplantation / adverse effects
  • Liver Transplantation / methods*
  • Models, Statistical
  • Non-alcoholic Fatty Liver Disease / mortality
  • Non-alcoholic Fatty Liver Disease / surgery*
  • Practice Patterns, Physicians'
  • Reoperation / statistics & numerical data
  • Risk Assessment / methods
  • Risk Factors
  • Severity of Illness Index
  • Tissue Donors / statistics & numerical data
  • Tissue and Organ Procurement / methods*
  • Tissue and Organ Procurement / trends
  • Treatment Outcome
  • Validation Studies as Topic